Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
As research continues to evolve, healthcare providers are encouraged to stay informed about the latest findings related to tirzepatide, semaglutide, and other weight management therapies
15 JungmannP
Studies of SEMA in metabolic liver disease have shown improvement in steatohepatitis with daily administration, but the results have been less satisfactory regarding the improvement of fibrosis at stages F2F3 or F4,30 or with a weekly dose of 2.4 mg over 72 weeks.31 The results of the new phase III ESSENCE trial, evaluating SEMA 2.4 mg over 240 weeks, are highly anticipated
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
US$ 25.95
US$ 20.18
US$ 26.90
US$ 25.37
US$ 24.24
US$ 22.94
US$ 28.69
US$ 21.65
US$ 26.23
US$ 26.04
